Now accepting consultation and second-opinion requests in North Texas.

Research & Professional Record

The work, with the receipts attached.

Peer-reviewed publications, FDA trial identifiers, patent filings, and licence numbers — published so they can be checked rather than taken on trust. 6,000+ procedures across 15+ years in practice.

Research & Partnership EnquiriesClinical Profile

Credentials

Every licence number is public record.

Published deliberately. A credential a reader can check is worth more than an adjective they cannot.

Board Certification

American Board of Neurological Surgery

Diplomate since 2020. Written examination 2011; oral board 2020.

Verify certification (opens in a new tab)

Fellowships

  • FAANS — American Association of Neurological Surgeons (2020)
  • FACS — American College of Surgeons (2020)
  • FCNS — Congress of Neurological Surgeons

Medical Licences

Active and prior state licensure, with numbers for verification.

Texas
S8418
North Dakota
12655
Minnesota
57514
Kentucky
42909
Oklahoma
37622

Clinical Trials

Principal investigator, two FDA IND programs.

Both use the same allogeneic umbilical-cord mesenchymal stem cell drug substance across a tauopathy and an orthopedic indication.

  • IND 32912

    XytriX™ — Chronic Traumatic Encephalopathy (CTE)

    Phase 1/2

    Authorised to proceed by FDA CBER, June 2026. 24-subject dose escalation.

    RMATBreakthrough Therapy

  • IND 32759

    XytriX™ — Knee Osteoarthritis (KOA)

    Phase 1/2

    FDA “Study May Proceed” determination, April 2026.

Investigational. These therapies are under clinical investigation. Safety and efficacy have not been established, and they are not available as treatment. Nothing here is an offer to enrol or a recommendation.

Peer-Reviewed Publications

Published research.

  1. Long-Term Re-operation Rates and Health Related Cost With Surgical Treatment of Lumbar Spondylolisthesis

    Journal of Bone and Joint Surgery J Bone Joint Surg. 2013;95:162(1-10)

  2. Cyst-ventricle stent as primary or salvage treatment for posterior fossa arachnoid cysts

    Journal of Neurosurgery: Pediatrics J Neurosurg Pediatr. 2011;7(5):549-556

  3. Trigeminal Neuralgia: Review of Difficult Cases with Historical Perspectives on Current Medical and Surgical Treatment Modalities

    Kentucky Medical Association Journal J Ky Med Assoc. 2011;109(12):357-362

  4. Endoscope-assisted surgical resection of a large epidermoid tumor through an 18mm trephination

    Kentucky Medical Association Journal J Ky Med Assoc. 2010;108(7)

  5. The Role of Chondroitin Sulfate in Early Avian Development

    Developmental Biology Dev Biol. 1999;210:242

Book chapters & peer review

Malignant Peripheral Nerve Sheath Tumor — AANS / ABNS Maintenance of Certification, co-authored with Dr. Allan Belzberg, Johns Hopkins University (2013).

Reviewer, Neurosurgery — peripheral nerve surgery and spinal pathology.

Patent Filings

Devices and systems, filed with the USPTO.

All applications are pending. A pending application is not a granted patent, and none of these describe a product currently available.

  • USPTO · Pending

    BCI-Based Exoskeleton

    Mobility via brain-computer interface and exoskeleton technology.

  • USPTO · Pending

    Doc-in-a-Box

    Remote consultation, checkup, and surgery via telemedicine.

  • USPTO · Pending

    Wheelchair Automation using BCI

    Wheelchair control via brain-computer interface and multi-mapping.

  • USPTO · Pending

    Holistic Mental, Behavioral & Emotional Wellbeing Assessment System

    Assessment system for mental, behavioural, and emotional wellbeing.

  • USPTO · Pending

    Minimally Invasive SI Joint Implant

    Implant for minimally invasive sacroiliac joint fusion.

Surgical Firsts

Where the technique arrived first.

  1. 2024

    First awake SI joint fusion using navigation

    Performed in Texas, in a clinical setting. Reported as a world first for the awake, navigated technique.

  2. 2022

    First robotic spine surgery in the Middle East and Africa

    Performed in Abu Dhabi, UAE, in March 2022.

  3. 2019

    First robotic spine surgery in North Dakota

    First robotic-assisted spine procedure performed in the state.

  4. 2011

    Spinal cord stimulator implantation for paralysis

    Performed with the Chairman of Neurosurgery at the University of Louisville as part of an experimental trial. Results in any individual case depend on the injury and clinical circumstances.

Honours

  • 2024Ajman Medal of HonorH.H. Sheikh Humaid bin Rashid Al Nuaimi, Ruler of Ajman
  • 2024Distinguished International Arab Festival Award (DIAFA)DIAFA, Dubai
  • 2013Kentucky ColonelGovernor Steven Beshear, Commonwealth of Kentucky
  • 2013Award for highest research publications among residentsUniversity of Louisville, Department of Neurosurgery
  • 2007Alpha Omega Alpha Medical Honor SocietyWright State University

Appointments

Current and prior roles.

  1. Founder & Managing Partner

    Minimally Invasive Neurosurgery PLLC

    2021–present

    The Dallas Regenex practice — robotic and navigated spine surgery, peripheral nerve surgery.

  2. Chief Medical & Strategic Officer

    TriCelX

    2024–present

    Clinical and scientific strategy for an allogeneic UC-MSC therapy platform.

  3. Chief Medical Officer & Co-Founder

    AverCare Global

    2024–present

    Medical strategy and clinical governance for an AI-driven healthcare platform.

  4. Director of Spine Surgery

    Texoma Neuroscience Institute

    2026–present

    Previously Chairman, Department of Neurosurgery (2020–2024).

  5. Director of Spine Surgery

    Sanford Health, Fargo

    2017–2020

  6. Chairman, Department of Neurosurgery

    Essentia Health, Fargo

    2014–2017

On the Record

Published statements.

Comment given to named outlets, with the date and subject attached.

  • Whether the hits came from an IED or an offensive line, the disease I see is the same, and for my entire career I have had nothing to offer but management of the decline.

    · TriCelX / EIN Presswire · on First FDA-authorised cell therapy trial in CTE

  • XytriX targets the chronic microglial neuroinflammation driving GSK-3β-mediated tau hyperphosphorylation at its source.

    · TriCelX / EIN Presswire · on Blast traumatic brain injury and the federal mandate

  • CTE is a tauopathy. Its defining lesion is the pathological accumulation of hyperphosphorylated tau as neurofibrillary tangles, placing it in the same biological family as Alzheimer's disease, frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration.

    · TriCelX / EIN Presswire · on CTE as a tauopathy platform indication

Media

Abu Dhabi TV · Dubai TV — weekly medical correspondent · Dubai One · MBC · The National · WAM (Emirates News Agency) · Khaleej Times · Gulf News · Ortho Spine News

Collaboration

Research, advisory, and partnership enquiries.

For clinical trial collaboration, advisory work, speaking, or medical-technology partnerships, contact the office directly.

Contact the OfficeCall (469) 947-7463
Research, Publications & Clinical Trials | Dallas Regenex